- Acute on chronic liver failure in cirrhosis
-
Tonon M, Piano S
- KMID: 2528258
- Clin Mol Hepatol.
- 2022 Apr;28(2):273-275.
- doi: 10.3350/cmh.2022.0036
-
- CITED
-
- Close
- SHARE
-
- Close
- KASL clinical practice guidelines for management of chronic hepatitis B
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2528259
- Clin Mol Hepatol.
- 2022 Apr;28(2):276-331.
- doi: 10.3350/cmh.2022.0084
-
- CITED
-
- Close
- SHARE
-
- Close
- Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
-
Lin HY, Tseng TC
- KMID: 2528247
- Clin Mol Hepatol.
- 2022 Apr;28(2):181-182.
- doi: 10.3350/cmh.2022.0028
-
- CITED
-
- Close
- SHARE
-
- Close
- Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open
-
Kim BH
- KMID: 2528245
- Clin Mol Hepatol.
- 2022 Apr;28(2):174-176.
- doi: 10.3350/cmh.2021.0400
-
- CITED
-
- Close
- SHARE
-
- Close
- Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
-
An J, Shim JH
- KMID: 2528256
- Clin Mol Hepatol.
- 2022 Apr;28(2):267-268.
- doi: 10.3350/cmh.2022.0013
-
- CITED
-
- Close
- SHARE
-
- Close
- Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
-
Kawaguchi T, Torimura T
- KMID: 2528246
- Clin Mol Hepatol.
- 2022 Apr;28(2):177-180.
- doi: 10.3350/cmh.2021.0246
-
- CITED
-
- Close
- SHARE
-
- Close
- Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
-
Takamura S, Teraki Y, Katayama E, Kawaguchi T, Kawaguchi M, Nakano D, Tsutsumi T, Nagoshi S, Nakama T, Torimura T
- KMID: 2528257
- Clin Mol Hepatol.
- 2022 Apr;28(2):269-272.
- doi: 10.3350/cmh.2022.0040
-
- CITED
-
- Close
- SHARE
-
- Close
- Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
-
Huang YC, Chen CW, Wei JCC
- KMID: 2528255
- Clin Mol Hepatol.
- 2022 Apr;28(2):265-266.
- doi: 10.3350/cmh.2021.0412
-
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
-
Lee J, Kim T, Yang H, Bae SH
- KMID: 2528249
- Clin Mol Hepatol.
- 2022 Apr;28(2):196-206.
- doi: 10.3350/cmh.2021.0371
Background/Aims: Non-alcoholic fatty liver disease (NAFLD) has become a major concern in Korea since its emergence as a dominant cause of chronic liver disease. However, no study has explored its... -
- CITED
-
- Close
- SHARE
-
- Close
- Approaches to quantifying hepatitis B virus covalently closed circular DNA
-
Zhang H, Tu T
- KMID: 2528242
- Clin Mol Hepatol.
- 2022 Apr;28(2):135-149.
- doi: 10.3350/cmh.2021.0283
Chronic hepatitis B is a major cause of liver disease worldwide and is currently incurable. Hepatitis B virus (HBV) covalently closed circular (ccc) DNA is a key form of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients
-
Liu WY, Zhang X, Li G, Tang LJ, Zhu PW, Rios RS, Zheng KI, Ma HL, Wang XD, Pan Q, de Knegt RJ, Valenti L, Ghanbari M, Zheng MH
- KMID: 2528248
- Clin Mol Hepatol.
- 2022 Apr;28(2):183-195.
- doi: 10.3350/cmh.2021.0301
Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is closely associated with metabolic dysfunction. Among the multiple factors, genetic variation acts as important modifiers. Klotho, an enzyme encoded by the klotho (KL)... -
- CITED
-
- Close
- SHARE
-
- Close
- The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
-
Lee HL, Lee SW
- KMID: 2528241
- Clin Mol Hepatol.
- 2022 Apr;28(2):121-134.
- doi: 10.3350/cmh.2021.0239
Transjugular intrahepatic portosystemic shunt (TIPS) is an effective interventional procedure to relieve portal hypertension, which is a main mechanism for the development of complications of liver cirrhosis (LC), such as... -
- CITED
-
- Close
- SHARE
-
- Close
- Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats
-
Yoon KT, Liu H, Zhang J, Han S, Lee SS
- KMID: 2528252
- Clin Mol Hepatol.
- 2022 Apr;28(2):232-241.
- doi: 10.3350/cmh.2021.0141
Background/Aims: Galectin-3 plays a key pathogenic role in cardiac hypertrophy and heart failure. The present study aimed to investigate the effects of galectin-3 on cardiomyopathy – related factors and cardiac... -
- CITED
-
- Close
- SHARE
-
- Close
- MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
-
Kawaguchi T, Tsutsumi T, Nakano D, Eslam M, George J, Torimura T
- KMID: 2528243
- Clin Mol Hepatol.
- 2022 Apr;28(2):150-163.
- doi: 10.3350/cmh.2021.0310
Fatty liver is now a major cause of liver disease in the Asia-Pacific region. Liver diseases in this region have distinctive characteristics. First, fatty liver is frequently observed in lean/normal-weight... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
-
Han JW, Kim DI, Nam HC, Chang UI, Yang JM, Song DS
- KMID: 2528251
- Clin Mol Hepatol.
- 2022 Apr;28(2):219-231.
- doi: 10.3350/cmh.2021.0082
Background/Aims: Sarcopenia is an independent prognostic factor of liver cirrhosis (LC). However, the association between LC-related systemic inflammation and sarcopenia is unclear. Methods: Sprague-Dawley rats were treated with thioacetamide (TAA) or... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-effectiveness of chronic hepatitis C screening and treatment
-
Lee HW, Lee H, Kim BK, Chang Y, Jang JY, Kim DY
- KMID: 2528244
- Clin Mol Hepatol.
- 2022 Apr;28(2):164-173.
- doi: 10.3350/cmh.2021.0193
Hepatitis C virus (HCV) infection is the second most common cause of chronic liver disease in South Korea, with a prevalence ranging from 0.6% to 0.8%, and HCV infection incidence... -
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis
-
Jeong J, Shin JW, Jung SW, Park EJ, Park NH
- KMID: 2528254
- Clin Mol Hepatol.
- 2022 Apr;28(2):254-264.
- doi: 10.3350/cmh.2021.0314
Background/Aims: Tenofovir alafenamide (TAF) has shown less favorable effect on lipids compared to tenofovir disoproxil fumarate (TDF) in clinical trials. However, data regarding these outcomes in patients with chronic hepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area
-
Kim BH, Lee D, Jung KW, Won YJ, Cho H
- KMID: 2528253
- Clin Mol Hepatol.
- 2022 Apr;28(2):242-253.
- doi: 10.3350/cmh.2021.0355
Background/Aims: Primary liver cancer is one of the leading causes of cancer mortality worldwide. However, the causes of death have not been studied in detail in patients with liver cancer. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma
-
Lee J, Jin YJ, Shin SK, Kwon JH, Kim SG, Suh YJ, Jeong Y, Yu JH, Lee JW, Kwon OS, Nahm SW, Kim YS
- KMID: 2528250
- Clin Mol Hepatol.
- 2022 Apr;28(2):207-218.
- doi: 10.3350/cmh.2021.0294
Background/Aims: We compared the post-treatment overall survival (OS) and recurrence-free survival (RFS) between patients with Child-Turcotte-Pugh (CTP) class-A and single small (≤3 cm) hepatocellular carcinoma (HCC) treated by surgical resection... -
- CITED
-
- Close
- SHARE
-
- Close
